Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Calzia 2013 Abstract MiP2013

From Bioblast
Calzia E, Wagner K, Wagner F, Groeger M, Matallo J, McCook O, Wachter U, Vogt J, Radermacher P (2013) Studying mitochondrial effects of sulfide. Does the species matter? Mitochondr Physiol Network 18.08.


Enrico Calzia

MiP2013, Book of Abstracts Open Access

Calzia E, Wagner K, Wagner F, Groeger M, Matallo J, McCook O, Wachter U, Vogt J, Radermacher P (2013)

Event: MiPNet18.08_MiP2013

Several investigations demonstrated that a hibernation-like metabolic state characterized by reduced energy expenditure and hypothermia can be induced in mice that have inhaled 80-100 ppm of H2S [1,2,3]. These observations suggest the exciting prospect of pharmacologically controlling energy expenditure in severe trauma and disease states by protecting against transitory hypoxia. However, equivocal data available from studies on large animals still raise serious doubts on the genuine effects of H2S on cell metabolism and mitochondrial function. In fact, data from sheep or swine failed to show any metabolic effect [4,5], and the effects observed injecting the intravenous sulfide donor Na2S in pigs are still controversial [6,7]. Obviously, body temperature is a major confounder in most animal studies on sulfide, as it can be easily modified, deliberately or accidentally, in murine experiments, but is hard to control in larger species. Therefore, it is still not clear which impact non-toxic doses of sulfide may have in-vivo on metabolic or mitochondrial functions beyond eventual temperature related effects.

In the last few years we performed experiments on the effects of sulfide in anesthetized and mechanically ventilated mice using a setting closely resembling an intensive care unit [8]. A closed loop control of body temperature allowed to efficiently separate genuine effects of sulfide and body temperature. Our data obtained ex-vivo by measuring mitochondrial respiration in small liver biopsies by means of high-resolution respirometry performed with the O2k-Oxygraph (Oroboros Instruments, Innsbruck, AT) suggest that low (non-toxic) sulfide concentrations per se do not suppress mitochondrial respiratory activity (Figure 1, A and B). Nevertheless, sulfide normalised the amount of LEAK-respiration, which was increased in septic animals under normothermia, an effect which was not related to any change in body temperature (Figure 1, C and D).

In conclusion, the main premise for studying mitochondrial effects of sulfide in animal models should be an efficient control of body temperature in order to clearly separate the effects of both factors. Technically, this can be done most easily in small animals like mice. Of course, the question remains to which extent data obtained in mice may be translated to larger mammalian species. Further preliminary data obtained on tissue biopsies from mice and pigs, however, indicate that sulfide is processed in a very similar way at the cellular level in different mammalian species, thus suggesting that the effects of sulfide at the mitochondrial level may be comparable between the species.

O2k-Network Lab: DE Ulm Radermacher P

Labels: MiParea: Respiration, Comparative MiP;environmental MiP, mt-Medicine  Pathology: Sepsis 

Organism: Pig, Mouse  Tissue;cell: Liver 

Enzyme: Complex IV;cytochrome c oxidase  Regulation: Inhibitor, Temperature  Coupling state: LEAK, OXPHOS, ET 

HRR: Oxygraph-2k 

H2S, MiP2013, S05 

Affiliations and author contributions

Ulm University, Dept of Anesthesia, Section of Anesthesiological Pathophysiology and Process Development, Ulm, Germany. - Email: [email protected]

Figure 1

FIGURE 1: Mitochondrial respiration in mice ex-vivo after 5 h of mechanical ventilation. Treatments were control (closed bars) vs. sepsis (CLP-induced, light bars), intravenous Na2S (diagrams B and D) vs. placebo (diagrams A and C), and 38 °C (red bars) vs. 27 °C (blue bars). All data are means and SD. LEAL, OXPHOS, and ET-pathway respiration were almost equal regardless of the sulfide treatment (A vs. B), but LEAK ratios (L/E) as well as the P/E ratio were significantly increased at 38 °C in the septic animals (light red bars in diagram C) but normalised under sulfide treatment (diagram D). Mitochondrial respiration was measured at 37 °C in all groups regardless of the temperature of 38 °C or 27 °C of the animals under anesthesia and mechanical ventilation.


  1. Blackstone E, Morrison M, Roth MB (2005) H2S induces a suspended animation-like state in mice. Science ???: 308-518.
  2. Volpato GP, Searles R, Yu B, Scherrer-Crosbie M, Bloch KD,Ichinose F, Zapol WM (2008) Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology 108: 659–668.
  3. Blackstone E, Roth MB (2007) Suspended animation-like state protects mice from lethal hypoxia. Shock 27: 370–372.
  4. Haouzi P, Notet V, Chenuel B, Chalon B, Sponne I, Ogier V, Bihain B (2008) H2S induced hypometabolism in mice is missing in sedated sheep. Respir Physiol Neurobiol 160: 109–115.
  5. Li J, Zhang G, Cai S, Redington AN (2008) Effect of inhaled hydrogen sulfide on metabolic responses in anesthetized, paralyzed, and mechanically ventilated piglets. Pediatr Crit Care Med 9: 110–112.
  6. Simon F, Giudici R, Duy CN, Schelzig H, Oter S, Gröger M, Wachter U, Vogt J, Speit G, Szabó C, Radermacher P, Calzia E (2008) Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia/reperfusion injury. ??? 30: 359–364.
  7. Drabek T, Kochanek PM, Stezoski J, Wu X, Bayir H, Morhard RC, Stezoski SW, Tisherman SA (2011) Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs. Shock 35: 67–73.
  8. Baumgart K, Wagner F, Gröger M, Weber S, Barth E, Vogt JA, Wachter U, Huber-Lang M, Knöferl MW, Albuszies G, Georgieff M, Asfar P, Szabó C, Calzia E, Radermacher P, Simkova V (2010) Cardiac and metabolic effects of hypothermia and inhaled hydrogen sulfide in anesthetized and ventilated mice. Crit Care Med 38: 588–595.